LEP and non-small cell lung carcinoma: Therefore, translational research targeting leptin and/or its receptor as therapeutic molecules and design of NSCLC animal experiments that mimic treatment regimens might be promising as therapeutic strategies for NSCLC cancer treatment, driving progress in the field of lung cancer research.